Ovid Application Error
Ruxolitinib as first-line treatment in secondary hemophagocytic lymphohistiocytosis: A second experience. Zandvakili, Inuk 1; Conboy, Caitlin B. 1,2; Ayed, Ayed O. 2; Cathcart-Rake, Elizabeth J. 2; Tefferi, Ayalew *,2 [Article] American Journal Of Hematology. 93(5):E123-E125, May 2018.
(Format: HTML, PDF)